HK Stock MarketDetailed Quotes
03759 PHARMARON
- 13.900
- -0.380-2.66%
Market Closed Dec 16 16:08 CST
24.84BMarket Cap2.00P/E (TTM)
14.460High13.820Low3.43MVolume14.200Open14.280Pre Close48.17MTurnover1.14%Turnover Ratio2.37P/E (Static)1.79BShares24.85052wk High0.28P/B4.19BFloat Cap7.98052wk Low1.30Dividend TTM301.34MShs Float93.548Historical High1.304Dividend LFY4.48%Amplitude7.980Historical Low14.062Avg Price100Lot Size9.38%Div YieldTTM9.38%Div Yield LFY
PHARMARON Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 3.00%8.82B | -0.63%5.6B | -1.95%2.67B | 12.39%11.54B | 15.64%8.56B | 21.70%5.64B | 29.53%2.72B | 37.92%10.27B | 39.63%7.4B | 41.06%4.63B |
| Operating income | 3.00%8.82B | -0.63%5.6B | -1.95%2.67B | 12.39%11.54B | 15.64%8.56B | 21.70%5.64B | 29.53%2.72B | 37.92%10.27B | 39.63%7.4B | 41.06%4.63B |
| Cost of sales | ---- | -4.27%-3.76B | ---- | -14.21%-7.44B | ---- | -19.24%-3.6B | ---- | -36.58%-6.52B | ---- | -44.17%-3.02B |
| Operating expenses | -6.36%-5.83B | -4.27%-3.76B | -2.84%-1.8B | -14.21%-7.44B | -16.60%-5.48B | -19.24%-3.6B | -24.28%-1.75B | -36.58%-6.52B | -39.81%-4.7B | -44.17%-3.02B |
| Gross profit | -2.97%2.99B | -9.30%1.85B | -10.55%872.15M | 9.22%4.09B | 13.95%3.08B | 26.31%2.04B | 40.16%974.97M | 40.31%3.75B | 39.34%2.7B | 35.59%1.61B |
| Selling expenses | 3.80%-186.56M | 3.02%-122.95M | 0.41%-55.47M | -9.87%-252.78M | -18.94%-193.92M | -17.27%-126.78M | -18.95%-55.7M | -47.84%-230.07M | -56.20%-163.04M | -69.63%-108.11M |
| Administrative expenses | 0.62%-1.21B | 0.50%-841.22M | 3.81%-398.61M | -7.75%-1.67B | -17.15%-1.21B | -27.89%-845.44M | -42.63%-414.38M | -70.85%-1.55B | -73.19%-1.04B | -72.34%-661.07M |
| Research and development expenses | -11.96%-332.25M | -14.06%-207.8M | -21.82%-93.61M | -58.78%-448.28M | -67.22%-296.76M | -117.74%-182.18M | -93.81%-76.84M | -86.02%-282.33M | -61.55%-177.47M | -29.79%-83.67M |
| Profit from asset sales | -9,732.09%-23.92M | ---- | -17,640.70%-20M | ---- | 118.51%248.31K | ---- | 124.01%114K | ---- | -17.65%-1.34M | ---- |
| Revaluation surplus | -155.03%-22.12M | ---- | -103.94%-1.13M | ---- | -48.12%40.2M | ---- | -36.42%28.58M | ---- | 328.45%77.49M | ---- |
| -Changes in the fair value of other assets | -155.03%-22.12M | ---- | -103.94%-1.13M | ---- | -48.12%40.2M | ---- | -36.42%28.58M | ---- | 328.45%77.49M | ---- |
| Impairment and provision | -25.70%-29.68M | -114.13%-22.94M | -48.33%-6.47M | -69.33%-35.83M | -95.17%-23.61M | -69.00%-10.71M | -1,025.65%-4.36M | -106.03%-21.16M | -82.15%-12.1M | -1,443.01%-6.34M |
| -Other impairment is provision | -25.70%-29.68M | -114.13%-22.94M | -48.33%-6.47M | -69.33%-35.83M | -95.17%-23.61M | -69.00%-10.71M | -1,025.65%-4.36M | -106.03%-21.16M | -82.15%-12.1M | -1,443.01%-6.34M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -414.60%-81.24M |
| Special items of operating profit | 521.30%659.56M | 549.74%742.27M | 81.86%64.63M | 65.17%336.11M | 132.75%106.16M | 53.44%114.24M | 210.94%35.54M | -57.25%203.49M | -72.56%45.61M | 623.82%74.45M |
| Operating profit | 22.45%1.76B | 41.44%1.4B | -29.53%331.85M | 8.28%2.02B | 3.79%1.44B | 32.05%986.57M | 30.70%470.91M | 1.54%1.87B | 13.73%1.38B | 11.03%747.14M |
| Financing cost | -21.96%-132.74M | -55.29%-138.25M | -61.25%-63.44M | -8.89%-182.19M | 32.76%-108.84M | ---89.03M | 2.22%-39.34M | ---167.31M | -1,282.67%-161.87M | ---- |
| Share of profits of associates | ---- | -375.96%-30.31M | ---- | 93.84%-2.08M | ---- | 347.40%10.98M | ---- | -147.12%-33.85M | ---- | 36.52%-4.44M |
| Special items of earning before tax | 28.90%-5.36M | ---- | 104.11%204.32K | ---- | 51.46%-7.54M | ---- | -27.90%-4.97M | ---- | -349.98%-15.53M | ---- |
| Earning before tax | 22.78%1.62B | 35.04%1.23B | -37.03%268.62M | 10.29%1.84B | 9.40%1.32B | 22.33%908.53M | 34.92%426.6M | -12.80%1.67B | 0.41%1.21B | 11.53%742.7M |
| Tax | -35.54%-252.67M | -15.63%-143.91M | 31.07%-52.7M | 18.50%-256.11M | 29.20%-186.42M | 29.84%-124.46M | 3.50%-76.45M | -8.02%-314.25M | -32.55%-263.29M | -49.56%-177.4M |
| After-tax profit from continuing operations | 20.69%1.37B | 38.12%1.08B | -38.33%215.92M | 16.98%1.58B | 20.16%1.13B | 38.70%784.07M | 47.77%350.15M | -16.54%1.35B | -5.95%944.18M | 3.29%565.3M |
| Earning after tax | 20.69%1.37B | 38.12%1.08B | -38.33%215.92M | 16.98%1.58B | 20.16%1.13B | 38.70%784.07M | 47.77%350.15M | -16.54%1.35B | -5.95%944.18M | 3.29%565.3M |
| Minority profit | -1,064.87%-52.59M | -1,404.05%-30.46M | -873.86%-14.64M | 14.03%-19.32M | 73.33%-4.51M | 89.94%-2.03M | 115.59%1.89M | 45.14%-22.47M | 53.15%-16.93M | -14.80%-20.13M |
| Profit attributable to shareholders | 24.82%1.42B | 41.64%1.11B | -33.80%230.56M | 16.48%1.6B | 18.51%1.14B | 34.28%786.09M | 39.81%348.26M | -17.24%1.37B | -7.59%961.11M | 3.65%585.43M |
| Basic earnings per share | 24.85%0.8028 | 41.42%0.6282 | -33.94%0.13 | 16.55%0.9033 | 18.81%0.643 | -10.10%0.4442 | -6.42%0.1968 | -44.60%0.775 | -38.18%0.5412 | 4.00%0.4941 |
| Diluted earnings per share | 24.89%0.8019 | 41.37%0.6271 | -34.01%0.1298 | 16.54%0.9019 | 18.75%0.6421 | -10.18%0.4436 | -6.29%0.1967 | -43.47%0.7739 | -38.11%0.5407 | 4.04%0.4939 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
HK
Overall
Symbol
Price
% Chg
No Data
